✦ LIBER ✦

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial

✍ Scribed by Robert Frederich, Robert McNeill, Niklas Berglind, Douglas Fleming, Roland Chen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of saxagliptin in dr

✍ Chang Yu Pan; Wenying Yang; Conrad Tou; Ingrid Gause-Nilsson; June Zhao 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

Glucose-lowering activity of the dipepti

✍ J. Rosenstock; S. Sankoh; J. F. List 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Long-term treatment with the dipeptidyl

✍ M. Nowicki; I. Rychlik; H. Haller; M. Warren; L. Suchower; I. Gause-Nilsson; K-M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

Efficacy, safety and dose-response relat

✍ Kadowaki, T.; Kondo, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

Efficacy and safety of the dipeptidyl pe

✍ R. E. Pratley; M. S. Kipnes; P. R. Fleck; C. Wilson; Q. Mekki; Alogliptin Study 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB